Baricitinib (Olumiant) Now Approved in Canada for Alopecia Areata
on Friday Jan 26, 2024, Health Canada approved baricitinib for the treatment of severe alopecia areata. This makes it the second approved JAK inhibitor in Canada. Ritlecitinib was approved in early December 2023. Baricitinib is sold under the name Olumiant and Ritlecitinib is sold under the name Litfulo. Our DonovanMedical youtube channel has extensive discussion of both drugs.
VIDEO DISCUSSING RITLECITINIB
VIDEO DISCUSSING BARICITINIB
This article was written by Dr. Jeff Donovan, a Canadian and US board certified dermatologist specializing exclusively in hair loss.